Correct renal function evaluation is based on estimated glomerular filtration rates (eGFR) and complementary renal damage biomarkers, such as neutrophil gelatinase associated lipocalin (NGAL). The aim of this study was to evaluate eGFR and NGAL modifications and renal impairment during treatment with a direct acting antiviral (DAA) for chronic hepatitis C virus (HCV) infection.
Evolution of glomerular filtration rates and neutrophil gelatinase-associated lipocalin during treatment with direct acting antivirals / Strazzulla, A.; Coppolino, G.; Barreca, G. S.; Gentile, I.; Rivoli, Lidia; Postorino, M. C.; Mazzitelli, M.; Greco, G.; Costa, C.; Pisani, V.; Marascio, N.; Simeoni, Anna; Focas, Germana; Fuiano, Laura; Foti, D.; Gulletta, Salvatore; Torti, C.. - In: CLINICAL AND MOLECULAR HEPATOLOGY. - ISSN 2287-2728. - 24:2(2018), pp. 151-162. [10.3350/cmh.2017.0059]
Evolution of glomerular filtration rates and neutrophil gelatinase-associated lipocalin during treatment with direct acting antivirals
Gentile I.;RIVOLI, Lidia;SIMEONI, ANNA;FOCAS, GERMANA;FUIANO, LAURA;Foti D.;GULLETTA, SALVATORE;
2018
Abstract
Correct renal function evaluation is based on estimated glomerular filtration rates (eGFR) and complementary renal damage biomarkers, such as neutrophil gelatinase associated lipocalin (NGAL). The aim of this study was to evaluate eGFR and NGAL modifications and renal impairment during treatment with a direct acting antiviral (DAA) for chronic hepatitis C virus (HCV) infection.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
